Pew funds 10 Latin American scientists to conduct research on world's most troubling health problems

Ten scientists were named Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts today. The fellowship provides support to advance grantees' research, enables them to study with prominent U.S. scientists, and invests seed capital to help them establish laboratories in their home countries. It provides flexible funding to postdoctoral researchers investigating some of the world's most troubling health problems-including diabetes, schizophrenia, and cancer.

"The quest for impactful biomedical discoveries is a global effort, and our 22-year history of promoting an international exchange of scientific ideas is a proud one-with more than 200 Latin American scientists receiving support," said Rebecca W. Rimel, president and CEO of Pew. "I have no doubt that this year's class will be a powerful force in advancing scientific and intellectual capital throughout the Americas."

The Pew Latin American Fellows Program was launched in 1991 to cultivate outstanding researchers and to strengthen the infrastructure of biomedical science in Latin American countries. The program provides each fellow with salary support for two years of postdoctoral training in the laboratory of an established researcher in the United States. In some cases, those mentors come from the community of Pew Scholars in the Biomedical Sciences-the sister program to the Pew Latin American Fellows Program. The scholars program has for 28 years supported promising U.S. scientists early in their careers.

The Latin American fellowships are designated by a distinguished national advisory committee chaired by Torsten N. Wiesel, M.D., president emeritus of Rockefeller University and a 1981 Nobel laureate in physiology or medicine.

"Scientific discoveries and innovations are, as we all know, not limited by geographic boundaries. This year's Pew Latin American Fellows are among the most creative and committed scientific students to be found anywhere in the world," said Wiesel. "They will undoubtedly further advance our scientific understanding and knowledge in biology and medicine."

As of 2008, 20 percent of foreign citizens who earned doctorates in the science, engineering, or health fields in the United States reported returning to their country of origin to work or live, according to the National Science Foundation. By contrast, more than 70 percent of the Pew fellows return to their home countries to set up their own laboratories. In addition to the $30,000-a-year stipend that fellows receive while training in the United States, the program also offers $35,000 to those who go back.

To date, Pew has dedicated more than $18 million in direct support for more than 200 Latin American fellows.

The 2013 Pew Latin American Fellows in the Biomedical Sciences and the laboratories in which they will train are:

Argentina

Estefan-a Bello, Ph.D.
Laboratory of Eric Kandel, M.D.
Columbia University
Neuroscience

Diego Fernandez, Ph.D.
Laboratory of Samer Hattar, Ph.D.
Johns Hopkins University
Neuroscience

Diana Posadas, Ph.D.
Laboratory of Richard Carthew, Ph.D.
Northwestern University
Developmental and RNA biology

Sabrina Sanchez, Ph.D.
Laboratory of Steve Kay, Ph.D.
University of Southern California
Genetic regulation and circadian rhythm

Brazil

Paulo Jos- Teixeira, Ph.D.
Laboratory of Jeff Dangl, Ph.D.
University of North Carolina at Chapel Hill
Plant biology and pathogenesis

Chile

Carlos Blondel, Ph.D.
Laboratory of Matthew Waldor, M.D., Ph.D.
Brigham and Women's Hospital
Cell biology and pathogenesis

Marco Contreras, Ph.D.
Laboratory of Jean-Marc Fellous, Ph.D.
University of Arizona
Neurobiology and behavior

Andres Herrada, Ph.D.
Laboratory of Dario Vignali, Ph.D.
St. Jude Children's Research Hospital
Immunology

Ecuador

Sof-a Oca-a, Ph.D.
Laboratory of Mario Grijalva, Ph.D.
Ohio University
Infectious disease

Mexico

V. Julian Valdes, Ph.D.
Laboratory of Elena Ezhkova, Ph.D.
Mount Sinai School of Medicine
Genetic regulation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk